LitAlert ~~

    • Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes.
    • Yap TA, Hamilton E, Bauer T, Dumbrava EE, Jeselsohn R, Enke A, Hurley S, Lin KK, Habeck J, Giordano H, Shapiro GI.
    • JCO Precis Oncol. [2022 Feb 9];6:e2100456. doi: 10.1200/PO.21.00456.
    • Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study.
    • Saad M, Mokrab Y, Halabi N, Shan J, Razali R, Kunji K, Syed N, Temanni R, Subramanian M, Ceccarelli M, Qatar Genome Programme Research Consortium, Tabrizi AR, Bedognetti D, Chouchane L.
    • Lancet Oncol. 2022 Feb 9:S1470-2045(21)00752-X. doi: 10.1016/S1470-2045(21)00752-X. Epub ahead of print.


    Genetic risk of cancer: a tale of diversity from the Middle East.